Skip Navigation

Christina M. Dieli-Conwright, PhD, MPH


Population Sciences


Researcher

  • Member of Faculty, Dana-Farber Cancer Institute and Harvard Medical School

Contact Information

  • Office Phone Number617-582-8321

Bio

Dr. Dieli-Conwright received her BS in Biological Sciences from California Polytechnic State University San Luis Obispo and her MS in Kinesiology from California State University Northridge. She earned a MPH, and PhD in Biokinesiology from the University of Southern California. Following a postdoctoral fellowship in Cancer Etiology at the City of Hope National Medical Center, she was the Director of the Integrative Center for Oncology Research in Exercise and Assistant Professor of Biokinesiology and Medicine at the University of Southern California. In 2020, she joined the faculty of the Dana-Farber Cancer Institute and Harvard Medical School.

Fellowship:

  • City of Hope National Medical Center

Recent Awards:

  • Young Investigator Award, Global Breast Cancer Conference, 2019
  • Top Cancer Health Disparities Abstract Award, 2019
  • Fellow, Transdisciplinary Research in Energetics and Cancer (TREC) Training Workshop, 2017
  • Mentoring Award for Graduate Students, 2017
  • Fellow, American College of Sports Medicine, 2016
  • Excellence in Teaching, Division of Biokinesiology and Physical Therapy, 2013
  • NCI-TREC Knowledge & Education Expansion Project (KEEP) Award: Travel award, 2010
  • National Cancer Institute (NCI) Travel Award Scholarship: Transdisciplinary Research in Energy and Balance (TREC) Energy Balance, Cancer Prognosis and Survivorship Conference, 2009

Research

Using an “Exercise is Medicine” approach, Dr. Dieli-Conwright's research is centered on testing personalized exercise interventions to improve cancer outcomes among individuals across the lifespan diagnosed with cancer.
Rooted in clinical exercise physiology, her research examines mechanisms by which post-diagnosis exercise can impact cancer outcomes with a specific focus on biomarkers related to body composition, inflammation, metabolic dysregulation, and cognition. She derives randomized controlled trials to test whether various types of prescriptive exercise improve cancer outcomes in individuals diagnosed with cancer, across the lifespan from adolescents and young adults to older adults. Additionally, she examines cardiometabolic diseases in minority cancer survivors and utilizes lifestyle interventions to reduce the onset of comorbidities that are more prevalent in minority cancer survivors.
Thus far, her work has largely focused on breast cancer, as Dr. Dieli-Conwright currently leads clinical trials examining the effect of exercise on body composition, adipose tissue inflammation, and cognitive function in breast cancer survivors. She also leads investigations in endometrial, colorectal, prostate, and hematologic cancers. Dr. Dieli-Conwright has a history of funding from the National Cancer Institute, American Cancer Society, American Institute for Cancer Research, and foundation grants.

Location

Dana-Farber Cancer Institute
375 Longwood Avenue
The MASCO Building LW743
Boston, MA 02215
Get Directions

Top